Purpose: A minimally invasive, partial-assist, intra-atrial blood pump has been proposed, which would unload the left ventricle with a flow path from the left atrium to the arterial system. Flow modulation is a common strategy for ensuring washout in the pump, but it can increase power consumption because it is typically achieved through motor-speed variation. However, if a pump's performance curve had the proper gradient, flow modulation could be realized passively. To achieve this goal, we propose a pump performance operating curve as an alternative to the more standard operating point.

Methods And Results: Mean-line theory was employed to generate an initial set of geometries that were then tested on a hydraulic test rig at ~20,000 r/min. Experimental results show that the intra-atrial blood pump performed below the operating region; however, it was determined that smaller hub diameter and longer chord length bring the performance of the intra-atrial blood pump device closer to the operating curve.

Conclusion: We found that it is possible to shape the pump performance curve for specifically targeted gradients over the operating region through geometric variations inside the pump.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0391398817752291DOI Listing

Publication Analysis

Top Keywords

intra-atrial blood
12
blood pump
12
minimally invasive
8
flow modulation
8
performance curve
8
pump performance
8
operating region
8
pump
7
operating
5
preliminary design
4

Similar Publications

Article Synopsis
  • Intracardiac masses, like myxomas, can sometimes be identified following a stroke, but distinguishing them through echocardiography can be challenging.
  • A case study involved a 58-year-old man with various health issues who suffered an ischemic stroke; his echocardiogram showed a large mass in the left atrium, leading to a diagnosis of myxoma after surgery.
  • Myxomas may not show symptoms for a long time and can be linked to embolic complications, emphasizing the need for a comprehensive, team-based management approach.
View Article and Find Full Text PDF

Two patients with hypoplastic left heart syndrome (HLHS) concomitant with cor triatriatum underwent the staged Norwood procedure following hybrid palliation. Cor triatriatum was diagnosed after birth in both cases. Case 1 with aortic stenosis and mitral atresia underwent bilateral pulmonary artery banding at 2 days of age.

View Article and Find Full Text PDF

In this paper, we present the design and fabrication of a novel chip-on-tip catheter, which uses a microcamera and optical fibres to capture in vivo images in a beating porcine heart thanks to a saline flush to clear the blood field. Here, we demonstrate the medical utility and mechanical robustness of this catheter platform system, which could be used for other optical diagnostic techniques, surgical guidance, and clinical navigation. We also discuss some of the challenges and system requirements associated with developing a miniature prototype for such a study and present assembly instructions.

View Article and Find Full Text PDF

In vivo cardiovascular profile of ryanodine receptor 2 inhibitor M201-A: Utility as an anti-atrial fibrillatory drug for patients suffering from heart failure with preserved ejection fraction.

J Pharmacol Sci

November 2024

Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan; Kazuya Yokoyama Cancer Research Institute, 1-4-8 Ueno, Taito-ku, Tokyo, 110-0005, Japan. Electronic address:

Atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) often coexist; however, clinically available anti-AF drugs can exacerbate symptoms of HFpEF. M201-A suppressed ryanodine receptor-mediated diastolic Ca leakage, possibly inhibiting common pathological processes toward AF and HFpEF. To bridge the basic information to clinical practice, we assessed its cardiohemodynamic, anti-AF and ventricular proarrhythmic profile using halothane-anesthetized dogs (n = 4).

View Article and Find Full Text PDF
Article Synopsis
  • Cardiac amyloidosis (CA) is often overlooked as a cause of heart failure and involves left atrial (LA) myopathy, which worsens prognosis and is linked to atrial fibrillation (AF).
  • This study evaluated the echocardiographic features of LA myopathy in patients with transthyretin (ATTR) and light-chain (AL) CA compared to those with hypertensive heart disease (HHT).
  • Findings showed that both ATTR and AL patients had significant heart function impairments, particularly in LA-MD, which was associated with a higher risk of mortality, highlighting the importance of LA evaluations in CA prognosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!